Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  streptozocin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 65 for your search:
Start Over
Phase II/III Chemotherapy with Streptozotocin plus 5-FU or ADR vs Chlorozotocin for Metastatic, Unresectable, or Recurrent Primary Islet Cell Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3278
Phase II/III Chemotherapy with SZC/5-FU vs ADR/5-FU for Unresectable Carcinoid Tumors, with DTIC for Failures (Summary Last Modified 07/89)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1281
Phase III Chemotherapy with FAM-S (5-FU/ADR/MITO/SZC) vs a Phase II Drug for Locally Inoperable or Metastatic Pancreatic Adenocarcinoma, a Master Protocol
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor: NCI
Protocol IDs: SWOG-8040
Phase II - III Study of Chemotherapy with MeCCNU, SZC/CTX and SZC/5-FU for Advanced Unresectable Pancreatic Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2272, MAYO-706013
Master Protocol for Phase II-III Chemotherapy for Pancreatic Carcinoma --- PALA vs SAM (STZ/ADR/MeCCNU)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2279
Phase II and III Chemotherapy with Streptozotocin Alone and Combined with 5-FU or CTX for Pancreatic Islet Cell and Carcinoid Tumors
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3272, MAYO-706011
Chemotherapy with 5-FU, Streptozotocin, Spironolactone and L-PAM for Advanced Nonmeasurable Pancreatic Carcinoma (Summary last modified 06/97 ko)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-5274, MAYO-706031
Phase III Chemotherapy with MOF (MeCCNU/VCR/5-FU) vs MOF-STREP (MOF plus SZC) for Advanced, Measurable Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-024-235, MSKCC-7814
Phase III Chemotherapy with Mitomycin-C/5-FU with or without Streptozotocin for Pancreatic Adenocarcinoma (Summary Last Modified 07/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7738
Phase III CVPP (CCNU/VBL/PCB/PRED) Alone or in Combination with Involved or Extended Field Radiotherapy for Stage I/II Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 16
Sponsor: NCI
Protocol IDs: CLB-7751
Phase III Chemotherapy with MOF-Strep (MeCCNU/VCR/5-FU/SZC) vs 5-FU/HU for Dukes C/D or Recurrent Advanced Colorectal Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2281
Phase III Combination Chemotherapy with MOF (MeCCNU/VCR/5-FU) plus Streptozotocin for Metastatic Carcinoma of the Large Bowel and Rectum
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-7715R
Phase III VAM (VCR/ADR/MTX) vs ADR for Thyroid Carcinoma Not Amenable to Other Therapy Modalities
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-026-161, RPMI-997906
Phase III MOF-STREP (MeCCNU/VCR/5-FU/STZ) vs 5-FU Alone as Adjuvant Chemotherapy for Dukes Stage B2/C Colorectal Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: NCI-D81-024-368
Phase III Alternating MOPP (NM/VCR/PCB/PRED) and CABS (SZC/CCNU/ADR/BLEO) vs MOPP Alone for Stage III/IV Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor:
Protocol IDs: NCI-78-C-118, UMCC-7808, NCI-MB-114, NCI-T83-0983, T83-0983
Phase III Chemotherapy with SMF (SZC/MITO/5-FU) vs HexMF (HMM/MITO/5-FU) for Locally Unresectable or Metastatic Pancreatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-9382
Phase III Radiotherapy, 5-FU, and SMF (SZC/MITO/5-FU) vs SMF Alone for Locally Unresectable Pancreatic Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-9283
Phase III Comparison of 5-FU vs 5-FU/PALA vs 5-FU/LEV vs 5-FU/MeCCNU/VCR/SZC vs 5-FU/TdR for Unresectable or Metastatic Colorectal Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-804651, MAYO-804651, NCCTG-80-46-51
Phase III Combination Chemotherapy with ADR/MITO/5-FU/SZC in Patients with Advanced Gastrointestinal Tract Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 70
Sponsor:
Protocol IDs: NCI-D82-011-270, HOG-7902A
Phase III MEG vs MEG/DES vs Stilphostrol vs STZ for Previously Irradiated Hormone-Refractory Metastatic Prostatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NPCTG-1600
Phase III Radiotherapy plus 5-FU vs Combination Chemotherapy with FAM-S (5-FU/ADR/MITO/SZC) for Carcinoma of the Pancreas (Summary last modified 06/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8210
Phase III Randomized Trial of Adjuvant Radiotherapy plus Single-Agent Chemotherapy with 5-FU vs "Sandwich" Combination Chemotherapy with SMF (STZ/MITO/5-FU) plus Radiotherapy and 5-FU in Patients with Curatively Resected Pancreatic Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-9184, EST-2285, MAOP-5484, POA-57184, RTOG-8420, SWOG-8492, INT-0031
Phase III Chemotherapy with 5-Fluorouracil Alone or Combined with Tubercidin and Streptozotocin for Pancreatic Carcinomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 80
Sponsor:
Protocol IDs: CENOG-7230
Phase III Chemotherapy with SZC/ADR/5-FU in Patients with Advanced Carcinoma of the Pancreas
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DM-8285, NCI-V83-0361
Start Over